These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 15524028
1. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations]. Jahnz-Rózyk K, Targowski T, From S, Płusa T. Pol Merkur Lekarski; 2004 May; 16 Suppl 1():91-4. PubMed ID: 15524028 [Abstract] [Full Text] [Related]
2. [Relationship between disease severity, smoking index age and direct costs of hospital treatment of COPD exacerbations]. Targowski T, Jahnz-Rózyk K, From S, Płusa T. Pneumonol Alergol Pol; 2005 May; 73(1):32-5. PubMed ID: 16539181 [Abstract] [Full Text] [Related]
5. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland]. Jahnz-Rózyk K, Targowski T, From S. Pneumonol Alergol Pol; 2008 May; 76(6):426-31. PubMed ID: 19173191 [Abstract] [Full Text] [Related]
10. Costs of COPD exacerbations in the emergency department and inpatient setting. Dalal AA, Shah M, D'Souza AO, Rane P. Respir Med; 2011 Mar; 105(3):454-60. PubMed ID: 20869226 [Abstract] [Full Text] [Related]
11. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults. Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L. Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388 [Abstract] [Full Text] [Related]
13. Developing and applying a stochastic dynamic population model for chronic obstructive pulmonary disease. Hoogendoorn M, Rutten-van Mölken MP, Hoogenveen RT, Al MJ, Feenstra TL. Value Health; 2011 Dec; 14(8):1039-47. PubMed ID: 22152172 [Abstract] [Full Text] [Related]
14. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms. Lindberg A, Larsson LG, Rönmark E, Jonsson AC, Larsson K, Lundbäck B. COPD; 2007 Mar; 4(1):5-13. PubMed ID: 17364672 [Abstract] [Full Text] [Related]
15. Healthcare costs of COPD in Italian referral centres: a prospective study. Koleva D, Motterlini N, Banfi P, Garattini L, Study Group BIC. Respir Med; 2007 Nov; 101(11):2312-20. PubMed ID: 17681461 [Abstract] [Full Text] [Related]
16. Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis. Yu AP, Yang H, Wu EQ, Setyawan J, Mocarski M, Blum S. J Med Econ; 2011 Nov; 14(3):315-23. PubMed ID: 21500975 [Abstract] [Full Text] [Related]
18. Economic analysis in admitted patients with acute exacerbation of chronic obstructive pulmonary disease. Chen YH, Yao WZ, Cai BQ, Wang H, Deng XM, Gao HL, Huang JS, Wang XM. Chin Med J (Engl); 2008 Apr 05; 121(7):587-91. PubMed ID: 18466676 [Abstract] [Full Text] [Related]
20. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. Fan VS, Ramsey SD, Make BJ, Martinez FJ. COPD; 2007 Mar 05; 4(1):29-39. PubMed ID: 17364675 [Abstract] [Full Text] [Related] Page: [Next] [New Search]